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Introduction 
The outermost layer of the human eye is the cornea. Its outstanding properties such as 
avascularity and transparency enable the humans to see the world through it. The cornea is 
responsible for refraction of the incoming light, admitting and focusing it onto the retina. 
Furthermore, it serves as a protective barrier against microbes, pathogens and air-borne 
substances, as well as mechanical stimuli. The average diameter of the cornea is 
approximately 11.5 mm with 0.5-0.7 mm thickness. Physiologically, blood vessels do not 
penetrate the tissue, instead nutrients reach the cells via diffusion from the tear film at the 
ocular surface or from the aqueous humor on the posterior side, secreted by the ciliary body; 
oxygen is absorbed directly by the cornea from the air. Anterior to posterior direction, the 
human cornea has 5 officially recognized layers, the corneal epithelium being the foremost. 
This cellular layer - the first barrier of the eye against the outside world- consists of 5-6 strata 
of fast-cycling, non-keratinizing, squamous epithelial cells. As blinking constantly sheds the 
outermost layer, replacement of the epithelial cells from the underlying strata is continuous, 
under physiological conditions. The next layer is a thin, acellular interface membrane made 
up of collagen fibers - the so-called Bowman’s layer, which separates the corneal epithelium 
from the stroma. 
Occupying 90% of the thickness of the cornea, the stroma is a flexible layer, made up of 
water, proteoglycans and abundant amounts of collagen type I. The stroma is responsible for 
2/3 of the refractive power of the eye. It is scarcely populated by quiescent keratocytes 
known to synthesize the proteoglycans and collagens that make up the tissue. This complex 
network of approximately 200 layers of uniform collagen I and V fibrils is remarkable. The 
specific ultrastructural features enabling the dome-like shape of the tissue, stability, 
mechanical flexibility and orthogonally- stacked lamellae render the tissue completely 
transparent. Interestingly, the fibrils are uniform in diameter, around 31 nm in humans. The 
proteoglycans- mostly keratin and chondroitin- or dermatan-sulphate- bind to the collagens, 
forming bridges across the tissue. The fibers stretch towards the sclera where the arrangement 
changes to grouped. The corneal stroma develops from the neural crest during 
embryogenesis, which is also the origin of the mesenchymal tissues of the head. 
Adjoining to this is the presence of a recently described anatomical structure- the Dua’s layer, 
which is still debated in the scientific and medical community, however, it is thought to be an 
acellular structure, located between the stroma and the Descemet’s membrane. Another 
interface layer, the Descemet’s membrane, is thought to be acellular as well, serving as a 
basal membrane to support the corneal endothelium. Despite its name, the endothelial layer is 
not a classical vascular endothelium, however, it is made up of polygonal (mostly hexagonal), 
tightly adjoined cells, and is a squamous epithelial tissue. The cells are in direct contact with 
the aqueous humor, nourishing the endothelium, while oxygen is absorbed from the air. 
Corneal endothelial cells have a crucial role in the hydration of the stroma and the cornea as a 
whole, regulated by active molecular pumps on the cells’ surface, under physiological 
circumstances, essential in achieving perfect transparency. 
The cornea is exposed to external damage, being the foremost layer of the eye, and is able to 
recover from minor superficial wounds without complications. Deeper injuries and 
accompanying inflammation can severely impair vision and can cause chronic corneal 
blindness through haze formation. One of the most common conditions that affect the eyes is 
pollen allergy, causing minor discomfort, while the second most common one is the dry eye 
syndrome, mostly caused by air-conditioning devices. The acute inflammation of the cornea, 
keratitis is usually classified as non-infectious and infectious type. The first type, is usually 
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brought about by minor scratches, while the second type is brought by microbial infections 
provoked by contact lens wear or any other infections of the ocular surface that is treated by 
antibacterial and/or steroid eye drops. 
Corneal dystrophies are usually genetically inherited diseases, affecting both eyes. The 
conditions gradually progress, eventually leading to haze due to the dysfunction of one or 
more layers of the cornea. Most common of them is keratoconus, where thinning of the 
cornea makes the tissue to protrude and adopt a cone-like shape, as the name suggests. The 
exact causes are unknown and in most cases the cornea becomes stable after a few years of 
treatment, or in some cases the condition progresses, the symptoms worsen with the vision 
decreasing gradually and scarring occurs. Ultimately, corneal transplantation is the last and 
definite option for treatment. Fuchs’ dystrophy affects both eyes of mostly women and is 
another slowly progressing condition. The number of corneal endothelial cells decreases to a 
critical number and subsequently, fluid leakage into the cornea causes local edema, swelling 
and vision impairment. Therapy normally targets the reduction of swelling, although severe 
cases require transplantation. In lattice dystrophy, amyloid deposits appear in the corneal 
stroma, forming a lattice-shaped accumulation of the protein, gradually overtaking the 
stroma, often destructing the epithelium in the process. Corneal transplantation is the last line 
of therapy in severe cases, although the disease is known to be intermittent. Other conditions 
that can affect the cornea are Herpes Zoster infection and reactivation (from latency after 
chickenpox infection), or Herpes caused by herpes simplex virus- 1 (HSV-1), creating sterile 
non-healing ulcers in the cornea that can turn into stromal keratitis. Therapy of the most 
severe diseases includes full thickness- or partial (lamellar) transplantation of the cornea, 
however, there is a global shortage of donors, reportedly 1 cornea is available for 70 needed. 
Success rates for engraftment are relatively high, with a 5-30% rejection rate. Alternatively, 
keratoprosthesis (Kpro), an artificial cornea is sometimes the last resort for patients who had 
rejected multiple cornea transplantations. Despite the high success rates, complications can 
always from surgery occur, such as glaucoma, dislocation and local inflammation of the 
surrounding tissue.  
Since human donor tissue is scarce and at the same time transplantation is the only solution in 
the therapy of severe cases, alternative methods are called upon. Regenerative medicine could 
fill the void, as cellular therapies using stem cells are gaining momentum. The main 
challenge is represented by the distinct roles and functionality of the cells making up the 
cornea. Stem cells possess the ability and plasticity to turn into multiple types of cells in 
which they are located. Besides embryonic, adult mesenchymal and hematopoietic stem cells 
need to be specified. The ethical use of human embryonic stem cells (HESCs) is highly 
debated; furthermore, long-term studies have associated a tumorigenic potential to these cells. 
Induced pluripotent stem cells (iPSCs) have been generated by reprogramming differentiated 
cells and while these cells have similar properties for renewal, as embryonic progenitors, 
autologous iPSC have been known to activate the immune system and the reprogramming 
itself carries certain risks for tumor formation. On the contrary, adult stem cells have been 
shown to have a low potential to tumorigenesis, with equal beneficial effects in tissue 
regeneration by the replenishment of native stem cell pools, and specifically, adult 
mesenchymal stem cells (MSCs) have been attributed immunosuppressive effects. 
Nevertheless, certain types of adult MSCs are known to have a limited renewal capacity. 
Although stem cell research and regenerative therapy for the cornea is currently being 
undertaken worldwide, most of the methods utilizing tissue engineering and cellular therapy 
are under development or still in research stage, while only a few have made it to clinical trial 
phase. 
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Corneal epithelium 
The corneal epithelium consists of 5-6 layers of closely packed cells that quickly 
respond to any superficial damage affecting the layer. Cells are continuously shed by blinking 
and are replenished from stem cell niches, located at the basal epithelium of the corneoscleral 
border - the limbus. In this special microenvironment, protected by the eyelids, the progenitor 
cells of the corneal epithelium or limbal epithelial stem cells (LESCs) can maintain the 
undifferentiated state and renew the stem cell pool. A damaged or lost corneal epithelium 
induces centripetal migration of the LESCs from the niches towards the affected area, 
gradually differentiating into transient amplifying- (TAC), then mature epithelial cells. Due 
to the asymmetrical division displayed by LESCs -and stem cells in general, this capability of 
self-renewal enables the cells to completely regenerate the epithelial surface in the course of 
12-24 hours. Loss of LESCs, usually induced by chemicals, mechanical injuries or disease is 
a severe threat to the regenerative capacity of the corneal surface. During this condition 
known as limbal stem cell deficiency (LSCD), epithelial cells of the conjunctiva start 
proliferating and migrating towards the center of the cornea, attracting vessels and leading to 
corneal neovascularization, thus causing blindness. 
Autologous transplantation of limbal biopsies taken from contralateral, good eye of patients 
or close relatives, have been shown to have therapeutic benefit, and been around in use for 
the last 25-30 years, holding a success rate of 80%. The LESCs can be obtained from 
cadaveric tissue as well, however, this requires systemic immunosuppression, demonstrating 
lower success rates in long-terms. The amniotic membrane, an avascular tissue and a 
byproduct from child delivery, has been known to possess anti-inflammatory and anti-
angiogenic properties and been used to cover up limbal grafts to decrease the chance of 
rejection; the amniotic membrane has beneficial effects on its own, as well, in the prevention 
or treatment of partial LSCD. 
It was in 1997, that LESCs from limbal biopsies have been cultivated ex vivo, then 
reimplanted into the patients, showing long- lasting positive outcomes. Animal-free medium 
has also been used to culture and expand the cells in vitro. According to recent studies, 
contact lenses are appropriate carriers for the reintroduction of LESCs into recipients’ eyes. 
Despite the promising results, the success rate of such procedures is around 70%, and the 
method is not always sufficient for optimal recovery of vision. In 2015, the European 
Commission approved the commercialization of the first ATMP (advanced therapy medicinal 
product) using stem cells, called the Holoclar®, a technique using ex vivo expanded LESCs 
from biopsies and is a cornerstone of ocular regenerative medicine; however, its potential 
appears to be limited to the treatment of superficial damage (affecting only the corneal 
epithelium). 
Corneal stroma 
Keratocytes are responsible for the maintenance of the corneal stroma and its uniquely 
elaborate structure and consistency. These cells assume a dendritic morphology in vivo, 
however, during wound healing the cells can transform into myofibroblasts and deposit scar 
tissue, hampering the corneal transparency and adversely affecting vision. Stromal tissue 
obtained from cadavers and cultured in serum-containing media gives rise to adhering cells 
displaying a spindle-shaped morphology and a steady proliferation rate. Interestingly, corneal 
stroma cells (CSCs) in vitro, have been found to express markers that are usually present on 
adult MSCs. The distribution of these surface protein markers (e.g. CD73+, CD90+, CD105+; 
CD34-, CD45-, CD14-, CD11b-, CD79-, CD19-, HLA-DR-), the cells’ adherence to plastic 
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and the ability to perform the canonical trilineage differentiation into adipose- (fat), cartilage- 
and bone tissues in vitro, enables these cells to be considered as adult MSCs, as defined by 
the ISCT (International Society for Cellular Therapy). Another ability of MSCs- the 
immunosuppressive properties through secretion of anti-inflammatory cytokines, has also 
been confirmed on CSCs. Studies conducted on animals proved the true potential of CSCs in 
cellular therapy. The true origin of these cells is still debated, however and possibly, isolation 
of such cells activates them and/or different populations become dominant. Various types of 
cultivation media induce the in vitro stem cell phenotype of CSCs in different ways, and low 
serum or serum-free conditions have been shown to restore the keratocyte phenotype, at the 
expense of viability and ECM production.  
The most challenging part of corneal stroma-oriented regenerative research is the 
reproduction of the fine ultrastructure, arrangement and composition of the stroma itself. 
CSCs cultured in serum-containing medium secrete abundant amounts of ECM into the 
vessel. A study using 10% serum and ascorbic acid in the cultivation medium found that the 
ECM appeared to have a great resemblance to the composition of the native tissue, including 
collagens and sulphated proteoglycans, as well as apical-basal polarity of the cultured CSCs. 
Addition of transforming growth factor (TGF) 1 and 2 to the medium induced the 
deposition of fibrotic-, scar-like ECM in the cultures, while TGF 3 enhanced the production 
of normal, non-fibrotic structures- similar to the one by the control (no TGF)-, with an 
increased thickness of 60-70 m to 20 m. The production of de novo connective tissue in 
culture provides the cells a major advantage in tissue-engineering-based research and 
possible future clinical implication; however, this “in vitro tissue” does not replicate the 
flexibility and other biomechanical features of the cornea completely, as of yet. This led to 
another branch of corneal stroma-based research with an attempt to repopulate decellularized 
animal-derived corneas by human CSCs, thus minimizing the risk of rejection from 
xenotransplantation. 
Despite the ever-growing body of evidence, research groups worldwide have access to 
corneas from different sources (e.g.: waste from keratoplasties, tissue banks, morgues) and 
use various methods to obtain CSCs. There has not been a study to date investigating, 
whether there is any phenotypical difference in the cells or in the expression of specific genes 
generated by an enzymatic or an explant technique from different anatomical regions of the 
cornea. The evidence about CSCs is not as extensive as of LESC research, although, the 
potential of CSCs is undebated and the beneficial effect of MSCs in corneal reconstruction 
has been demonstrated in animal experiments, but the probability of applying the cells in 
clinical practice is still in its infancy. 
Corneal endothelium 
The most posterior layer of the cornea is not the classical vascular endothelium, instead it is 
made up of a single layer of tightly-packed squamous epithelial cells, responsible for the 
water homeostasis of the cornea. Initially, it was thought that these cells do not proliferate 
and are arrested in the G1 phase of the mitosis. If a cell dies, a neighbouring one would 
enlarge and fill in the gap left behind. Through aging or defects in the corneal endothelium, 
as cell density drops below a critical number, excess water leaks into the anterior cornea 
causing local edema, and damage to the tissue and ultimately vision impairment occurs. 
Recent discoveries led to a turning point in the way corneal endothelium is approached- it has 
been found capable of recovering from minor wounds. Presence of a putative progenitor cell 
population at the transitional zone between the corneal endothelium and the trabecular 
meshwork, called Schwalbe’s line has been suggested in one study, as the source of precursor 
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cells for both tissue types. Another study points at an increased density of cells around the 
peripheral endothelium, presumably identifying a renewed population of cells. Wound 
healing studies reported appearance of stemness markers in the peripheral corneal 
endothelium, although another study reported proliferative activity in only 10% of wounded 
samples. Still not conclusive, these results suggest, that the corneal endothelium is possibly 
capable for a delayed replacement of dead cells of the layer in vivo. 
Ongoing corneal endothelial research has been focused on the expansion of these cells 
in vitro. Production of viable, steadily proliferating and homogenous human corneal 
endothelial cell (HCEnC) cultures and thus reproducible data has been a major challenge of 
the past 30 years. Cultured HCEnC (re)gain the ability to proliferate in vitro, using serum-
containing medium at the expense of morphological shift, loss of functionality and possible 
contamination by other cell types. The cells in vivo, assume a perfect polygonal (hexagonal) 
morphology, while in culture a more polarized, elongated shape is present in long-terms. The 
process is thought to be the endothelial (epithelial)- mesenchymal transition (EndoMT or 
EMT), regulated by TGF2, causing a rearrangement of the microfilament system. Several 
studies have used Rho kinase inhibitors (ROCK) to constrain EMT by blocking the 
rearrangement of the microtubules temporarily, while affecting cell motility and proliferation. 
There are a few commercialized cell lines, although none of them represent the original cells 
adequately, as suggested by genomic analysis. HESCs have been successfully differentiated 
into HCEnCs, expressing functional markers, such as zonula occludens-1 (ZO-1) and Na/K 
ATPase, however the use of HESCs faces ethical problems and will not provide a long-term 
solution for the generation of clinically favorable products. 
Isolation of the cells from the corneal endothelium is usually achieved with the separation of 
the supporting Descemet’s membrane. Enzymatic treatment causes release of the cells from 
the basal membrane and dissociation from each other by the breakup of the tight junctions. 
The single cells attach to pre-treated culture vessels, exhibiting a sluggish expansion rate. 
Initially the cells display polygonal-like morphology, which then shifts into a more polarized 
cell shape, reportedly due to contamination by stromal cells or as a result of EMT. A few 
markers have been suggested for the assessment of HCEnC culture purity, such as 
CD166/ALCAM, glypican-4 and CD200, a study even details markers found on a sorted 
population of HCEnCs. 
A pre-clinical trial performed on monkeys proved to be unsatisfactory, when HCEnCs 
expanded on collagen I sheets were implanted; in another study, 243 patients were treated 
with injection of corneal endothelial cell suspension in a minimally invasive procedure. In the 
current study, HCEnC cultures have been generated by a method widely used by the 
scientific community, to characterize the expression of certain surface proteins and 
carbohydrates/ glycocomplexes, to set up a more robust “fingerprint” panel for the 
identification of these cells and to assess purity and homogeneity of the cultures. The role of 
protein and carbohydrate homeostasis of the cell has been implicated in events, such as cell 
adhesion, differentiation, development and cancer cell metastasis, therefore, it is generally a 
good indicator of the cells’ state and potential. Ample amount of research needs to be 
undertaken to set up the optimal, “golden standard” method for the successful isolation and 
cultivation of HCEnCs for tissue engineering and possible use in future clinical therapeutic 
procedures.  
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Aims of the study 
1. To investigate, whether various isolation methods can generate different populations 
of CSCs. 
2. To characterize cultured CSCs produced by the different methods and various 
anatomical regions in regards to their distribution of specific surface- markers’ 
expression related to stemness and cellular adhesion. 
3. To explore the magnitude of change that CSCs go through, when expanded ex vivo 
by comparing the gene and protein expression demonstrated by the native versus 
cultured cells and in regards to markers related to functionality, stemness, adhesion 
and proliferation. 
4. To isolate and cultivate cells from human corneal endothelium and explore their 
phenotypic characteristics. 
5. To compare the gene expression of certain function-related and other previously 
described markers in CSCs versus HCEnCs. 
6. To characterize the state of HCEnCs based on their surface protein and carbohydrate 
distribution and thus generate a fingerprint capable of assessing the purity of cultured 
cells. 
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Materials and methods 
Cell isolation and cultivation 
Cadaveric tissue was collected in accordance with the directives of the Helsinki 
Declaration are was approved by the Hungarian National Medical Research Council 
(14387/2013/EKU-182/2013). Donors were obtained within 24 hours of death. The bulbi 
were disinfected, then corneal buttons were removed with surgical tools. In Petri dishes, the 
endothelium together with the Descemet’s membrane were peeled away and treated with 
collagenase enzyme for 3 hours, to dislodge the cells from the basal layer. Corneal 
endothelial cells were further separated by trypsinization and finally seeded into fibronectin-
coated culture wells. The anterior side of the leftover corneal button was thoroughly, but 
carefully scraped and rinsed to remove the corneal epithelium. A trephine was used to 
generate small punches of the corneal stroma, from central and peripheral regions, which 
were then explanted directly (CE and PE, respectively), or seeded after digestion, into 
culture plates (CD and PD, respectively). Primary HCEnCs have been cultured in 5% FBS- 
supplemented Endothelial medium for the first 2 days, then in Ham’s F12/M199, containing 
5% FBS, 1% insulin-transferrin selenite, 10 ng/mL bFGF and 0.02 mg/mL ascorbic acid. As 
a control, a commercially available corneal endothelial cell line, B4G12 was used. CSCs 
were cultured in 10% FBS- containing DMEM Low glucose. Cells were cultured under 
adhesive conditions and the medium was changed every alternate day. 
Reverse Transcription– Quantitative Polymerase Chain Reaction analysis (RT-qPCR) 
Total RNA was isolated from corneal endothelial, stromal and B4G12 cells, according to the 
instructions of the RNeasy kit. RNA from the native corneal stroma was extracted by Qiazol 
reagent (Qiagen). Reverse transcriptions were performed using the High Capacity cDNA 
Archive Kit (Applied Biosystems), Superscript III reverse transcriptase and random 
hexamers (Life Technologies). CDNA from B4G12 cells was amplified using a Mx3005P 
PCR system (Agilent Technologies). CDNA from primary cells was amplified by a 
StepOnePlus system (Applied Biosystems), using Taqman gene expression assays for 
ALDH1A1, ABCG2, AQP1, CD31, CD34, CD73, CD90, claudin14, CXCR4, cytokeratin-19, 
ENG (CD105), GPC4, ITGAV, ITGB4, KLF4, Nestin, Vimentin, ZO-1. Thermo cycling was 
set as 95°C for the first 10 minutes, then 40 cycles of 95°C for 15 seconds, finally 60°C for 1 
minute. 2−ΔΔCt method was used to analyse the expression of given genes and relative 
quantities were determined. All samples were run in triplicates. GAPDH and 18S RNA were 
included as housekeeping genes. 
Fluorescence-activated cell sorting (FACS) 
Surface protein distribution of HCEnCs and CSCs was analysed by FACS. Cells were 
collected from the culture plates and stained with 3 different flourochrome-conjugated 
antibodies, FITC, PE and APC, against ABCG2, CD31, CD34, CD44, CD47, CD49a, 
CD49d, CD51, CD54, CD73, CD90, CD105, CD106, CD112, CD146, CD166, CD325 and 
Nestin. All samples were analysed on a FACS Calibur cytometer (BD, Biosciences) and the 
results were evaluated using FCS Express 6 (De Novo Software) and Flowing Software 2.5 
(Perttu Terho). R software was used to plot the data for the hierarchical clustering. 
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Immunofluorescent- and lectin staining 
Paraffin-embedded human corneas have been sectioned and prepared for 
immunostaining procedure. Markers ABCG2, CXCR4, Nestin, Ki-67, ALDH1A1, Collagen 
I, CD34, CD73, CD90, CD105, Vimentin, Fibronectin, Collagen IV, VE-Cadherin, -actinin, 
ABCG5 and anti-fibroblast markers were used to stain full thickness corneas. After blocking 
the non-specific binding sites with 5% BSA, the slides were incubated with the primary 
antibodies listed above. After a brief wash, all samples were stained with Alexa Flour 488-
conjugated secondary antibodies, then nuclear stain, DAPI was applied. Pictures were 
captured using a Zeiss Axio Observer Z1 microscope. Primary HCEnCs were cultured in 
special 8-well chamber slides, then stained with antibodies against CD73, CD166, Collagen I 
and IV, Na/K ATPase, ZO-1 and Ki-67, similarly to the procedure described above. A BX51 
Olympus microscope was used to visualise the results. 
Primary HCEnC cultured in 8-well chamber slides were also incubated with FITC-conjugated 
lectins, Griffonia (bandeiraea) simplicifolia lectin I (GSL I) against galactose and N-
acetylgalactosamines, dolichos biflorus agglutinin (DBA), Peanut agglutuninin (PNA), 
Ricinus communis agglutinin I (RCA 120), Soybean agglutinin (SBA), Phaseolus vulgaris 
erythroagglutinin (PHA E) and Phaseolus vulgaris leucoagglutinin (PHA L) against 
galactose, Concanavalin A (CON A), Lens culinaris agglutinin (LCA) and Pisum sativum 
agglutinin (PSA) against mannose and glucose, fucose and arabinose were stained by Ulex 
europaeus (UEA I), while Wheat germ agglutinin (WGA) and its succinylated form (sWGA) 
bound sialic acid. Nuclei were stained by Hoechst 33342 and images were captured by an 
EVOS® FL microscope (Thermo Fisher Scientific). 
Statistical analysis 
Statistical analysis was carried out using Graphpad Prism 7, Microsoft Excel and SPSS. One-
way ANOVA, Student’s t-test and Mann-Whitney U-tests were used to calculate the p-
values. Significance level was set to <0.05 (p<0.05 *; p<0.01 **). Results were expressed as 
mean ± SD or SEM. 
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Results 
Cell morphology and proliferation of CSCs 
Cells from CD and PD were visible at plating proliferated fast and reached confluence 
in the course of 10-12 days, while CE and PE took 12-14 days to appear at the edges of 
explanted tissue, reaching confluence 20-25 days after isolation. The 4 conditions displayed 
no morphologically apparent differences. All cultures showed Ki-67 positivity. From all 
stained cells, 4.21 ±1.53%, 7.87 ± 4.73%, 8.60 ± 4.58% and 10.95 ± 4.42% demonstrated Ki-
67 expression for CD, CE, PD and PE, respectively. (p=0.43) 
Immunofluorescent staining of the native corneal stroma 
ABCG2 and ABCG5 could not be detected in the native cornea, while strong staining was 
observed for ALDH1A1, -actinin, CD31 and CD34 all over the stroma. Collagen I 
demonstrated a marked expression in the stroma, as well, while Collagen IV was not 
detected. CD73, CD90 and CD105, MSC markers were not present. Ki-67, CXCR4 and 
Nestin were negative in the native tissue, as well. Vimentin was found to be expressed, while 
Fibronectin was absent. No expression of other markers, such as anti-reticulocyte, fibroblast 
marker and VE-cadherin was detected in the native tissue. 
FACS analysis of cultured CSCs 
High expression of CD73, CD90 and CD105 was detected in cultured CSCs, with no 
difference between the 4 groups. ABCG2 and Nestin, were detected, as well, while CD34 and 
CD31 were not present on any of the cultured cells. CD51, CD49a, CD49d adhesion 
molecules and integrin-related CD47 were positively expressed, with no significant 
difference between the different conditions. 
Gene expression in the native- versus cultured cells of the corneal stroma 
CD73, CD90 and CD105 were upregulated in cultured CSCs, compared to the native tissue. 
Vimentin was upregulated in cultured cells, as well, 18-fold higher compared to the same 
control. CD34 was significantly downregulated in the cultured cells when compared to the 
cells from the native tissue. Similarly, CD31 was significantly downregulated in the cultured 
cells. ALDH1A1 was detected in the cultured cells with a significant downregulation 
compared to the native tissue. Expression of ABCG2 was upregulated 60-fold, while 
significantly lower expressions of AQP1, CXCR4, ITGB4 and KLF4 were observed in 
cultured CSCs. Expression of ITGAV and Nestin were upregulated in the cultured cells, 
while GPC4 expression was unaltered. 
Comparison of the gene expression of B4G12 and primary HCEnC to CSCs 
The cell line demonstrated a 15-fold lower expression of Vimentin than the CSCs. CD90 
expression was 13-fold higher, while Cytokeratin-19 was 3-fold more expressed in CSCs 
compared to the cell line. Zonula occludens (ZO-1) and Claudin 14 were more expressed in 
B4G12: 2.2-fold and 10-fold, respectively, when compared to CSCs. Similar to the cell line, 
primary HCEnCs demonstrated a lower expression of Vimentin, as much as 3.1-fold, 
compared to the CSCs. Expression of CD90 was 3.2-fold lower in primary HCEnCs, while 
Cytokeratin-19 was 7-fold lower than in CSCs. ZO-1 was 4.5-fold more expressed in 
HCEnCs. 
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Surface protein staining of HCEnCs (IHC and FACS) 
A moderate expression of CD73 was found in the cytoplasm of primary HCEnCs. 
CD166 was positive as well and mostly localized close to the cell membrane. Na/K-ATPase 
was positive, as well and mostly expressed around the edges of the cells. Presence of ZO-1 
was not detected in the cell junctions, but a dim signal was observed in the cytoplasm. 
Staining for Collagen I and Collagen IV revealed the presence of the proteins in the 
cytoplasm of the cells. Certain primary cells demonstrated the expression of nuclear Ki-67. 
Primary cells were isolated and stained without further cultivation, as controls for FACS 
analysis. Cultured HCEnCs demonstrated a high expression of CD73 (89.32±1.35%), while 
16.34±23.74% of uncultured cells showed a positive expression. Expression of CD90 was 
negative or low (7.16±4.46%) in primary HCEnCs and a similar trend was observed in 
uncultured cells, as well (8.56±13.26%). 49.52±17.26% of cultured HCEnCs expressed 
CD105. Most cultured HCEnCs expressed CD44 (68.39±13.13%), while it’s expression was 
significantly lower in uncultured cells (6.68±2.44%). CD47 was present on the majority of 
cultured cells (89.12±1.92%), while CD34 was not detected (0.13±0.13%). High expression 
of CD54 was observed (54.33±8.03%) and CD106 was expressed, as well (38.08±15.23%), 
with a high inter-donor variability on cultured cells. 43.02±15.53% of primary cultured cells 
expressed CD146, while uncultured HCEnCs demonstrated a lower expression of the protein 
(1.1±3.15%). Cultured HCEnCs demonstrated CD112 expression (77.73±2.17%), with two 
separate populations, both being positive. A low expression of CD166 was observed in 
uncultured cells (20.20±11.47%), while it was found to be increased in cultured HCEnCs 
(78.93±1.69%). Similar to CD112, staining for CD325 showed two distinct populations of 
cultured cells 76.39±5.68%. Uncultured HCEnCs also expressed CD325 (69.61±7.08%). 
Hierarchical clustering of the data from cultured HCEnCs and CSCs demonstrated a 
difference in the phenotype of the two cell types. 
Surface lectin-carbohydrate pattern of primary HCEnCs 
The cells expressed terminal galactose molecules, confirmed by Ricinus communis agglutinin 
I (RCA). Complex galactose structures were detected by Phaseolus vulgaris leucoagglutinin 
(PHA L). Succinylated and non-succinylated Wheat germ agglutinin (sWGA, WGA) were 
positive for HCEnCs, binding to dimer and trimer N-acetylgalactosamines. Mannose and D-
glucose monomers and polymers were recognized by Lens culinaris agglutinin (LCA), 
Phaseolus vulgaris erythroagglutinin (PHA E), Pisum sativum agglutinin (PSA) and 
Concanavalin A (CON A). Lectins Dolichos biflorus agglutinin (DBA), Soybean agglutinin 
(SBA), Griffonia (bandeiraea) simplicifolia lectin I (GSL I) did not show any N-
acetylgalactosamine monomers on the surface of HCEnCs. Presence of putative 
epithelial/endothelial marker L-fucose was not detected by Ulex europaeus (UEA I) and 
Peanut agglutinin (PNA) staining the T-antigen was negative on HCEnCs, as well. 
HCEnC viability 
81.84±11.44% of cultured cells was viable, with a considerable number of necrotic cells 
(26.55±15.79%), stained by propidium iodide (PI). 4.27±5.94% was the percentage of 
apoptotic cells (Annexin V FITC), while 5.5±4.23% of HCEnCs showed signs of secondary 
necrotic/late apoptotic state, confirmed by the double-stained cells. Similarly, trypan blue 
exclusion test showed an overall 80.01±11.92% viability in HCEnC cultures.  
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Discussion 
The world is facing a shortage of donors for corneal transplantation. Cell therapy could 
be a possible alternative and while the potential of stem cells from different origins has been 
demonstrated numerous times in animal models, their safe and efficient application in human 
reconstruction is further to be proven. Cells for drug testing, corneal research and potential 
cell therapy agents can be obtained from the human corneal stroma. Different countries and 
research groups have access to different parts of the cornea. Mostly, it is corneal rings after 
full thickness keratoplasties or lamellar procedures (DMEK or DSAEK) that are used for cell 
isolation. Others have access to the central parts of the cornea, as well. It is unknown, 
whether cells from the various sources generate different cell phenotypes. CSCs are able to 
replicate in vitro and have outstanding features that have been demonstrated by many 
research groups, including us. Notably, the CSCs phenotype adheres to the criteria 
established by ISCT for MSCs and the cells are also capable of the canonical trilineage 
differentiation. Moreover, possible immunosuppressive properties can be attributed to CSCs, 
in vitro. The characteristics mentioned above are only displayed by cultured and not by the 
resident stromal cells, in vivo. The origin of the cultured cells is thus debated, whether it is 
the stromal keratocytes that adapt to environmental changes or a small population of 
progenitor cells get activated in vitro. 
Whole mount corneas have been stained for previously described markers. No difference in 
the expression of the different anatomical regions was found. Putative stem cell efflux 
marker, ABCG2, was not detected on native cells and neither was ABCG5, while the cultures 
obtained from the central or peripheral parts of the cornea by the two methods showed high 
positivity for ABCG2. Upregulation of the protein might allow the cells to be more resilient 
to external stimuli (e.g. chemotherapy), as previously demonstrated by malignant cells. 
Strong staining for ALDH1A1 was detected in the native cornea. This molecule is a corneal 
crystalline and its expression is responsible for the transparency of the tissue, as the lack of 
ALDH1A1 is accompanied by the haziness of the cornea. Although equally present in both 
central and peripheral parts of the cornea in vivo, the expression of the gene was significantly 
downregulated in cultured CSCs as assessed by PCR.-actinin was detected throughout the 
cornea, including the keratocytes, thus this marker alone should not be used to exclude 
fibroblastic cells when assessing the purity of a culture. Vascular endothelial marker CD31 is 
thought to be involved in leukocyte migration. It mediates the attraction and adhesion of 
polymorphonuclear cells in wound healing. The native cornea elicited a considerable CD31 
expression, although the role of the protein in a healthy, avascular tissue is yet to be 
elucidated. Cultured CSCs presented here lose CD31 according to surface phenotyping and 
this downregulation was supported by results from PCR, as well. Possibly the most important 
marker of stromal keratocytes is CD34, has wide range of functions, most importantly in 
immunological events, such as eosinophil migration and mobility. Studies on CSCs have 
shown the gradual loss of CD34, during cultivation. Our results confirm this, the native 
cornea demonstrated a strong positivity, while cultured cells showed complete loss of the 
protein. The expression of the gene was significantly downregulated in cultured cells, 
compared to the native tissue. An important molecule, aquaporin-1, is known to be involved 
in the migration of the stromal keratocytes during wound healing, in vivo. It was found to be 
downregulated in the cultured CSCs, while others reported it to be expressed in vitro, as well, 
in an animal model. Markers of MSCs - CD73, CD90 and CD105, were not detected in the 
native tissue, however a strong staining was observed in the cultured CSCs. This was 
supported by gene expression analysis and adheres to findings of others. The appereance of 
the 3 mesenchymal markers and the loss of CD34 in culture is what makes the CSCs comply 
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to the ISCT criteria. Adult MSCs of different origin have similar surface expression patterns. 
Again, like CD34, CD90 is known to be involved in a wide range of actions, such as cellular 
and matrix adhesion, fibrosis, inflammation and tumor growth. Immunosuppressive 
properties of MSCs are attributed to CD73 and cultured CSCs retain the markers over long 
cultivation times and many passages.  
CSCs in culture synthesize considerable amount of extracellular matrix de novo, mostly 
Collagen I. The molecule is expressed abundantly in the native corneal stroma, as 
demonstrated by immunostaining, while Collagen IV could not be detected. The expression 
of integrin V (CD51) was upregulated in cultured cells, with a significant downregulation of 
Integrin 4, compared to in situ. This change in the balance of adhesion molecules and matrix 
components highlights the CSCs potential in responding to environmental changes. Intact 
corneas do not express fibronectin in situ, but the molecule appears temporarily during 
corneal wound healing in the stroma and epithelium. No sign of nuclear Ki-67 was detected 
in the native corneas, demonstrating a lack of damage and following cell proliferation. 
Cultured CSCs, however, did expressed this marker, highlighting the existence of actively 
proliferating cells in all the isolating and cultivation conditions presented in the study. 
Vimentin was strongly expressed in the healthy corneal stroma. This is in line with the 
findings of others and knockdown studies have showed that the absence of the protein is 
associated with the formation of corneal haze and thus subsequent visual impairment. Nestin, 
was not present in the cells in situ. It is believed to be responsible for the organization and 
rearrangement of filaments in the cells, and was found to be expressed in murine spheroid 
cultures and a putative population was described in rabbit corneas as well. Upregulation of 
the gene was detected in cultured CSCs compared to the native corneas in our study. Tissues 
directly exposed to the outside world as barriers are known to express KLF4, which is an 
important marker associated with stemness. Our results show a significant downregulation in 
the expression of the protein following isolation and cultivation. Similarly, a stem cell 
migratory marker, CXCR4 has been found to be expressed by MSCs of different origin and 
inhibition of the protein resulted in an incomplete migratory response to bone marrow and its 
upregulation has been implicated in EMT and cancer cell invasion. In the current study, 
CXCR4 expression was found to be negative in vivo and cultured CSCs elicited significantly 
decreased levels of the functional protein, as well, compared to the native cells, however 
roles of stemness markers KLF4 and CXCR4 in the cornea are not yet know. 
CSCs adopt characteristics of MSCs during cultivation, with a simultaneous downregulation 
of certain functional molecules- a matter to be addressed when using these cells for treatment. 
The potential of CSCs is unquestionable, with its beneficial effects demonstrated in several 
studies involving animals. Although cultivation can force these cells to a dramatic change as 
shown in this study, compromises must be made to be able to apply these cells for in vitro 
research, while not addressing them as corneal keratocytes. Most likely, there are several 
factors that contribute to the adoption of such a phenotype of the cells, including 
environmental changes or the presence of serum in the cultivation medium. The results of this 
study show that there are likely no phenotypic or genotypic differences between CSCs 
generated by different methods of isolation, from central or peripheral anatomical regions of 
the corneal stroma. The results also show a great plasticity of CSCs in response to external 
stimuli in culture and possibly in vivo, as well to counter wounding or inflammation. Whether 
this change is reversible and beneficial for the cells and thus could be safely used in human 
cell therapy in conditions affecting the eye or other organs is to be further researched. 
Successful isolation and cultivation, as well as obtaining reproducible data has been a major 
challenge for the research on corneal endothelial cells over the last 3 decades. To date, there 
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is no single consistent method for the ex vivo cultivation of functional HCEnCs. Reportedly a 
putative stem cell population exists in the zone between the corneal endothelium and the 
trabecular meshwork that could produce confluent monolayer over 7 passages. Although 
HCEnCs do not proliferate, in vivo, compensatory mechanisms have been described, in which 
DNA synthesis in the cells is upregulated, with migration near the damaged area. Recently, it 
was reported that corneal endothelial cells in situ can maintain their capacity to proliferate 
due to a possible arrest in G1 phase. All studies aim at generating a standard method for the 
isolation and expansion of HCEnCs to produce homogenous cultures of functional cells, with 
the implication of possible clinical use as an alternative to corneal transplantation. According 
to a pre-clinical trial, which included transplantation of HCEnCs spread on collagen I sheets, 
such procedure was found insufficient in monkeys, while another trial aimed at injecting 
HCEnC suspension in the front segment of the eye to treat patients. In the present study, we 
applied a previously reported method to obtain the cells by an enzymatic method to generate 
HCEnC cultures and characterize the resulting cell population, then compare it to a corneal 
endothelial cell line, B4G12. While the cell line showed a relatively steady expansion, 
primary HCEnCs took up to 3-4 weeks to achieve confluency in small culture wells. This 
could be indicative of a homogenous cell population of HCEnCs, as cultures overtaken by 
fibroblasts or contaminating stromal cells are real concerns of the scientific community. Also, 
it is belived that these cells undergo EMT, due to culturing over extended periods of time, 
suggested by apparent changes in morphology. Stromal cell contamination of primary 
HCEnC cultures is a concern, although data obtained from CR analyses showed a higher 
expression of certain genes related to cell adhesion, cellular junction formation and HCEnCs 
demonstrated a different pattern of gene expression from CSCs. This supports that the 
cultures established in the present study are likely free of stromal cells. Vimentin is marker of 
mesenchymal cells and a putative marker of EMT, although it has been described in the 
native corneal endothelium and the stroma, as well. CSCs expressed more Vimentin, than the 
B4G12 cell line and primary HCEnCs. Possibly, primary HCEnCs undergo EMT, while the 
cell line does not show such a change, however, the use of Vimentin alone to determine the 
presence of EMT is not sufficient. ZO-1, a crucial marker of functional and interconnected 
cells, was detected in primary HCEnCs and the cell line, both showing higher expression 
compared to CSCs. Claudin-14 was described in native corneal stromal cells, but only very 
low levels were detected by PCR, while no expression was found in primary HCEnCs. 
Claudin 14 was detected in CSCs and B4G12, with a higher expression in the cell line, 
although this is contradictory to the finding of others. Cytokeratin 19 expression is 
characteristic of the limbal epithelium and was found to exhibit low expression in HCEnCs 
and B4G12 compared to CSCs. These results indicate that while primary cells and the 
endothelial cell line express genes in a similar manner, the magnitude of expression differs 
and thus cannot be considered a great representation of each other. A study comparing the 
transcriptome of B4G12 versus primary cells found that the latter is more comparable to the 
gene expression observed in vivo. 
A recently reported panel for the surface marker expression of functional HCEnCs 
states that the cells express CD98, CD166 and CD340, while CD9+, CD49e+, CD44+ and 
CD73+ cells are post-EMT, thus not functional. FACS analysis revealed that the primary 
HCEnCs included in this study expressed CD44, CD73 and CD166. Epithelial cells with a 
damaged integrity to the layer are known to upregulate CD44, and its expression was found 
in other tissues of the body in highly proliferative cells. This phenomenon has also been 
described in the basal corneal epithelium and in CSCs, but not in the healthy corneal 
endothelium. Upregulation of CD44 expression has also been implicated in graft rejection, 
Fuchs dystrophy and bullous keratopathy, as well as diseases, in which tissue integrity is 
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compromised or when an injury is to be compensated. However, CD44 has not been detected 
in keratoconus, lattice and Meesmann dystrophies with intact, unaffected corneal 
endothelium. The majority of cultured HCEnCs showed positivity for CD44 in this study, 
contrary to the initial lack of expression observed in freshly isolated HCEnCs. Over 95% of 
cultured CSCs express CD73, CD90 and CD105, and while most HCEnCs were positive for 
CD73 and CD105, very low positivity (<10%) was observed for CD90. This was supported 
by data from freshly isolated HCEnCs. Consequently, it suggests, that the HCEnC cultures 
established in our study were likely free of stromal contamination. 
Up- and downregulation of glycoproteins have been shown to be a compensatory 
mechanism in epithelial injuries. Cultured HCEnCs showed a similar lectin staining as CSCs. 
Corneal diseases have been known to cause an altered carbohydrate/glycoconjugate 
expression. Mice with a mutation in the Pax-6 gene displayed impaired compensatory 
response to an in vitro simulated epithelial injury, when D-mannose, -D-glucose and -
N-acetylglucosamine 1-4 glucose were blocked by WGA and Con A. In situ lectin staining 
patterns of the corneal endothelium have been described previously in human and animal 
specimens and found WGA, Con A, RCA to be positive, while GSL I, SBA and UEAI were 
negative in healthy donors. In basal corneal epithelium, WGA, Con A, RCA, GSL I and PHA 
staining were reported, while Con A, PHA and PSA were positive for the Descemet’s 
membrane. Undamaged corneal endothelium demonstrated no binding of SBA, while 
positivity was observed around the edges of injured areas, eventually decreasing and 
disappearing over the course of 72 hours. It was also shown, that SBA altered actin 
rearrangement by binding to a specific component, during wound-healing experiments. This 
finding led to another set of experiments, in which the authors concluded, that the 
glycoprotein, bound by SBA is possibly involved in the restoration of cell interactions, as it 
was expressed by diseased or distressed cells trying to compensate the loss of layer integrity 
ex vivo. Moreover, SBA binding was described in keratoconus as well, suggesting a fine 
balance of surface carbohydrates in the maintenance of corneal physiology. No SBA binding 
was observed in this study on cultured primary HCEnCs, possibly explained by the change of 
environment and subsequent shift/ transformation of cell fate. 
Present work shows that a popular method for generating HCEnCs can produce cells 
expressing markers associated with the phenotype of corneal endothelial cells. While these 
cells are adapting to the new environment, they are possibly trying to restore the integrity of 
the layer they once represented. During cultivation however, the cells are likely to undergo 
EMT and lose certain important, functional molecules (ZO-1), while acquiring markers 
(CD44, CD73), that are not expressed, in situ. It remains a question, whether the functions 
can be safely restored with providing the original environment (i.e. reimplantation) without 
the use of agents altering cell functions, before applying them therapeutically in clinical 
practice. Future research with clinical relevance might use induced pluripotent stem cells to 
obtain homogenous cultures, with functional cells, until a standard method for the safe 
isolation and cultivation of these cells from cadaveric tissue is established and proven safe. 
Results presented in this study have demonstrated, that primary cells obtained from the 
human corneal stroma and endothelium are capable of producing viable cultures, however the 
cells do not fully represent their original functional forms. Nonetheless, both cells types have 
good a potential to become candidates for possible future ocular clinical recontructives 
therapy, once their use is proven safe, beneficial and efficient. 
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